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Hybrid photomultiplier tube and photodiode parallel
detection array for wideband optical spectroscopy
of the breast guided by magnetic resonance imaging
Fadi El-Ghussein, Michael A. Mastanduno, Shudong Jiang, Brian W. Pogue, and Keith D. Paulsen
Dartmouth College, Thayer School of Engineering, Hanover NH 03755
Abstract. A new optical parallel detection system of hybrid frequency and continuous-wave domains was devel-
oped to improve the data quality and accuracy in recovery of all breast optical properties. This new system was
deployed in a previously existing system for magnetic resonance imaging (MRI)-guided spectroscopy, and allows
incorporation of additional near-infrared wavelengths beyond 850 nm, with interlaced channels of photomultiplier
tubes (PMTs) and silicon photodiodes (PDs). The acquisition time for obtaining frequency-domain data at six wave-
lengths (660, 735, 785, 808, 826, and 849 nm) and continuous-wave data at three wavelengths (903, 912, and
948 nm) is 12 min. The dynamic ranges of the detected signal are 105 and 106 for PMT and PD detectors, respec-
tively. Compared to the previous detection system, the SNR ratio of frequency-domain detection was improved by
nearly 103 through the addition of an RF amplifier and the utilization of programmable gain. The current system is
being utilized in a clinical trial imaging suspected breast cancer tumors as detected by contrast MRI scans. © 2014
Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.19.1.011010]
Keywords: diffusion; imaging systems; magnetic resonance imaging; medical imaging; spectroscopy; tomography.
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1 Introduction
Diffuse optical tomography (DOT) with near-infrared (NIR)
light (600 to 1000 nm) transmitted/reflected through up to 12 cm
of tissue can be used to analyze and quantify vascular and tissue
features such as oxyhemoglobin, deoxyhemoglobin, water, and
lipids.1–4 This functional approach to imaging can be used in
pathophysiological change monitoring of breast tissue while
doing a magnetic resonance imaging (MRI) scan.5–10 In order
to achieve accurate spectroscopy of these molecules, ideally
a broad range of wavelengths across the NIR would be used.
In this study, the system integration to extend the spectral
range up to 948 nm wavelength is demonstrated through
the parallel integration of sensitive photodiode (PD) detectors
alongside a set of photomultiplier tubes (PMTs) in a unique
rotary switch array, optimized for high dynamic range data
acquisition, such as NIR breast imaging.
The challenge in NIR breast imaging is to provide a robust
system that has appropriate wavelength coverage with appropri-
ate dynamic range capability for the discrete sizes and attenu-
ations possible between women’s breasts imaged. Most DOT
systems operate at two to four wavelengths11 and, due to the
limited sensitivity of PMT detectors, use light between 650
and 850 nm.12–14 Later systems have evolved to include addi-
tional wavelengths. However, the larger lipid and water absorp-
tion peaks both lie at 930 and 975 nm, respectively.15
Recovering the water and lipid content is not that accurate with-
out coverage in this range. Adding these wavelengths has been
shown to improve the recovery of both chromophore con-
centrations in breast spectroscopy16,17 as well as NIR breast
tomography in an earlier version of the system.15,18 This earlier
attempt was not on a compact system, but rather utilized a large
spectrometer array, which was for initial prototype testing. In
the current rendition, a more compact system prototype was
engineered to test the ability to measure these signals and
quantify water and lipid.
Frequency-domain (FD) measurements using intensity-
modulated sources are extremely stable and cost effective, but
have the inherent limitation that most high dynamic range FD
systems are based upon PMT detection. PMT detectors in gen-
eral have low photon detection efficiency. The highest-gain
PMTs have wavelength response curves that fall off dramati-
cally above 825 nm, and so while these systems provide excel-
lent separation of μa and μ 0s , they do not provide for the best
wavelength coverage for optimal spectroscopy. The use of
steady-state continuous-wave (CWor low frequency modulated)
light to measure the attenuation of light at longer wavelengths
can supplement FD measurements, if combined in a manner
that utilizes the known spectral shapes as prior estimates of
the key molecules to be quantified.14,18 The system developed
here was designed with the idea of sequential illumination for
FD followed by CW, allowing the widest spectral range possible
for MRI-guided NIR spectroscopy of breast cancer.
In this study, a new NIR optical parallel detection system
of both frequency and CW domains was developed to improve
the data quality and accuracy in recovery of all breast optical
properties. In order to extend the measurements to longer
wavelengths while maintaining the system in a compact and
mobilized manner, rather than using CCDs for each detector as
previously tried,15,18 solid-state silicon PD detectors with a large
active area (10 mm × 10 mm) were used.
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These PDs have very high sensitivity (noise-equivalent
power ¼ 0.2 pWHz−1∕2) although they have significantly
smaller temporal bandwidth (1 KHz) as compared to PMTs.
Therefore, amplitude and phase measurements were used with
the FD instruments and CW measurements were obtained
with the PD detectors, but both were coupled into the same
breast fiber array, allowing flexible switching between them.
The acquisition time for all nine wavelengths from 660 to
948 nm is 12 min. The dynamic ranges of the detected signal
are 105 and 106 for PMT and PD detectors, respectively.
Compared to the previous detection system, the SNR of FD
detection was improved by nearly 103 through the addition of
an RF amplifier and utilization of programmable gain. The final
system allowed imaging at nine NIR wavelengths and provided
MRI-guided spectroscopy of breast tissues with tomographic
recovery of hemoglobin, oxygen saturation, water, lipids, and
scattering parameters. The new prototype is outlined in detail
here and system performance is analyzed.
2 Materials and Methods
The hybrid imaging system, shown in Fig. 1(a), was designed to
accommodate FD (Sec. 2.1) and CW measurements (Sec. 2.2).
All the FD/CW imaging components along with the rotary
switch array (Sec. 2.3)and the data acquisition (Sec. 2.4) and
control software are housed inside a single portable rack.
Fiber optic bundles held in thick cables connect the light detec-
tors to the patient breast interface (Sec. 2.6). In order to test and
validate the system, experiments on gelatin phantoms (Sec. 2.7)
and a healthy subject (Sec. 2.8) were performed.
A diagram of the hybrid system is shown Fig. 1(b). Detailed
description of the components and their interconnection is
described below. In brief, a bias-tee combines DC current along
with an RF signal (f ¼ 100.0005 MHz) in order to drive
the FD laser diodes, while a laser current module drives the
CW laser diodes. The output of the lasers is directed to the
tissue via fiber optic cables. The transmitted signal is recorded
using PMT detectors for FD measurements and then followed
by PD modules for the CW measurements that are used with the
longer wavelengths. The output of the PD modules is connected
directly to the data acquisition (DAQ) board, while the output of
the PMT detectors is converted to voltage, amplified, and then
heterodyned to a lower-frequency signal using mixers. The
output of the mixer is amplified further and then is read by
the DAQ board.
2.1 FD Detector Channels
The PMT modules were used with wavelengths below 850 nm
for FD measurements. The instrumentation for this portion,
illustrated in the schematics shown in Fig. 1(b), is nearly iden-
tical to our previously published system,13 with two important
upgrades, including (1) a 20 dB amplifier that was added after
each PMT and (2) a programmable gain amplifier on the DAQ
card. The light source consists of six intensity-modulated
(100 MHz) laser diodes that cover the main spectral range of
the four chromophores under study (660, 735, 785, 808, 826,
and 849 nm). A bias-T combines DC bias current from an ILX
Lightwave laser driver with a 100 MHz AC signal from a
Marconi function generator in order to drive the laser diodes.
The modulation depth of the lasers is 25 to 40%. The lasers
are activated one at a time by digitally controlling a six-way
RF switch, which passes the biased current to the selected
laser diode. Each laser diode is mounted on a fiber launch mod-
ule (Thorlabs, Princeton, New Jersey) where the output of each
laser is directed into the input of a 6 × 1 fiber optic combiner
(Fiberguide, Stirling, New Jersey). The output fiber is then
Fig. 1 FD/CW hybrid imaging system. A photo of the complete system is shown in (a). The system diagram is shown in (b). A photo of human subject
being imaged using the system.
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directed to the rotating stage, discussed in Sec. 2.3, where it acts
as the source fiber in the system.
PMT (H9305-3, Hamamatsu, Japan) detectors with a 1.4 ns
rise time are used to acquire the attenuated laser light that is
transmitted through tissue. The spectral response range of the
PMTs is 185 to 900 nm with peak sensitivity at 450 nm. The
sensitivity of the PMT decreases rapidly at wavelengths longer
than 850. Power to all PMTs is supplied from a single power
supply. Thin film filters (Kodal Wratten Red 25, Edmund
Optics) are installed on the detectors window in order to
block visible light below 600 nm from entering the PMTs.
The RF output of the PMT detectors is amplified using a
20 dB RF low-noise preamplifier (Minicircuits), which also fil-
ters out the DC component of the signal. Adding this amplifier
has increased the SNR by a factor of 100. The output of the
preamplifier is then heterodyned with a local oscillator (LO)
reference signal (100 MHz) in order to down-convert the
100.0005 MHz PMT output and produce an intermediate fre-
quency (IF) signal (500 Hz) that can be processed more easily
by the DAQ cards. The IF output of the mixer is then amplified
(100×) and filtered by a differential-amplifier/3-pole
Butterworth low-pass filter circuit in order to reduce high-fre-
quency noise before it is measured by the DAQ card. The result-
ing output signal is read by the DAQ card where it is phase-
locked with a reference signal in order to obtain the phase
and amplitude of the attenuated signal detected by the PMT.
The LO signal is obtained by dividing the power of a 13 dBm
100 MHz function generator output into 15 signals using a
1 × 16 RF splitter. Each output of the RF splitter is then con-
nected to the LO input of the mixers. One output is terminated
via a 50 Ohm terminator since only 15 mixers are used. The two
signal generators are synchronized and the reference signal used
for the phase-lock detection is obtained by mixing a portion of
the output of each signal generator. This reference signal is then
connected to the DAQ card where the phase from all channels is
compared with the phase of the reference signal.
2.2 CW Detector Channels
The CW measurement system extends the range of wavelengths
used to image the breast in order to better quantify the
chromophore concentrations. The system consists of three
laser diodes (903, 912, and 948 nm) and 15 silicon PD modules
that are housed in the same enclosure as the FD components.
The output of the laser diodes is intensity-modulated at 50 Hz
in order to obtain better SNR through software-based lock-in
detection as shown in Fig. 1(b).
The detectors used are high-precision silicon PD modules
that incorporate a current-to-voltage amplifier within the module
(C10439-03, Hamamatsu, Japan). These modules have an active
area of 1 cm2 and a large spectral response range (190 to
1100 nm) with peak sensitivity at 960 nm. The sensitivity of
the PD modules is switchable between a low and a high
range. The two PDs nearest to the laser source are set to low
sensitivity in order to avoid light saturation of the modules
while the remaining modules are set to high sensitivity. Thin
film filters (Kodak-87 Wratten, Edmund Optics, Barrington,
NJ) are installed on the detector’s window in order to block
light below 800 nm. All PDs are driven by a single dual-output
power supply. CW measurements only extract the change in
amplitude of the light through tissue. Therefore, unlike the
FD measurements, no additional components were needed to
connect to the PD modules. The output of the PDs is connected
directly to the DAQ cards.
2.3 Rotary Mechanical Switch Array
A portable rack contains all the FD and CW components includ-
ing laser diodes, signal generators, computer, and the detectors
array. The detectors array is housed inside a custom mechanical
switch as shown in Fig. 2, which was designed using Solid
Works and built in-house using ¼”-aluminum sheets. The
assembly (21 0 0 × 21 0 0) was designed to accommodate both
PD and PMT modules. The PD and PMT modules are mounted
on the top circular plate, while the RF splitter and mixers are
mounted on the bottom circular plate. Both circular plates rotate
via a high-precision motor mounted on the bottom circular plate
as shown in Fig. 2(a). This allows multiplexing of the laser
source and detectors to 16 different positions, giving a total
of 240 measurements (16 sources × 15 detector measurements)
for each wavelength. The detector’s position is always fixed rel-
ative to the source position. Fiber optic cables connect the
Fig. 2 Rotary switch array: Solidworks drawing of the array is shown in (a) and photos of the actual assembly are shown in (b) and (c).
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patient interface to the top square plate of the switch assembly.
A small gap exists between the top square plate and the circular
plate holding the detectors, which allows the circular plate to
rotate. Light from the fiber optic cables is multiplexed to all
detectors through holes in both the square and circular plates
that align with each other as the circular plates rotate. The fibers
remain fixed and thus the same fiber that was used for the source
is also used for detection.
2.4 Computer and Data Acquisition
A computer running custom LabVIEW software controls the
system components and enables automation of the entire sys-
tem. The program allows the user to select the lasers to be used
for imaging and provides advanced options that enable the user
to run different customizable scans. The LabVIEW software
controls the signal generators via general purpose interface bus,
the rotary stage through RS232, and two peripheral component
interface (PCI) DAQ cards.
A 16-bit 64-channel multifunction DAQ card (NI-PCI
6031E, National Instruments, Austin, TX) is used for acquiring
the data from the PMT. The FD signals are sampled at 4 KHz
and 1000 samples∕channel are acquired. The signal from each
FD measurement is then phase-locked with a reference signal
that is also connected to the same DAQ card. The phase and
amplitude of each channel is analyzed and recorded. The
CW data are sampled at 4 KHz and 2000 samples∕channel
are acquired.
The multifunction DAQ card used has a programmable gain
amplifier. The use of this digitally controlled amplifier ensures
that the analog FD/CW signals use the maximum resolution
of the analog-to-digital converter (ADC) of the DAQ card,
which improves the signal’s accuracy. Using this amplifier has
increased the SNR by a factor of 10. During acquisition, data
from each channel is sampled for 100 ms in order to find the
maximum and minimum of each channel. Once this range
is found, the appropriate gain is selected for each individual
channel and the signals are acquired again.
The gain of the PMT detectors is controlled by a 16-bit
16-channel static analog voltage output card (NI PCI-6703,
National Instruments). The gain is set by applying voltages
between 0.3 and 1.1 V in increments of 0.1 V.
2.5 Calibration
Calibration is a critical step needed in order to get meaningful
linear response of voltage data from the PD/PMT detector opti-
cal measurements. This takes into account amplitude losses
and phase delays that result from differences in the detector’s
response, optical fiber losses, and RF components performance.
The goal of the calibration process is to produce the same
response (amplitude and phase measurements) for equivalent
inputs across the entire dynamic range of the detectors. Three
types of calibrations were used as described below.
2.5.1 Individual PMT and PD responsivity correction
Detector responsivity calibration was used to account for the
differences in PMT responses to the same optical signal. The
relative sensitivity of each optical detector was quantified using
a single light source that was placed in the radial center of a
cylindrical homogenous phantom. The response of all the detec-
tors was measured and a scaling factor was obtained, which
corrects for slight differences of the intensity detected.
However, the signal detected is affected not only by differences
in the detector response and associated RF-circuitry, but also by
differences in the dispersion properties of the fiber bundles.
Since the detectors rotate while the fiber bundles remain fixed,
the scaling factors were obtained for each of the 16 different
source positions in order to correct for fiber bundle differences.
2.5.2 PMT gain calibration
Different light levels reach the PMT detectors depending on
their position from the source fiber. In order to account for
this difference, the PMToffers a large dynamic range. The large
dynamic range of a PMT is in part due to the ability to manipu-
late gain, which affects the light level that can be detected over
many orders of magnitude. But critically, the response of the
PMTs at different gain levels must be calibrated if the signal is
to be interpreted in a linear manner across these orders of mag-
nitude. The calibration process that was used is similar to the
calibration process that was described by Mastanduno et al.19
2.5.3 Homogenous calibration
Homogenous calibration is used to compensate for optical fiber
losses and any small errors that might develop during the detec-
tor calibration process, and also allows a better match of the data
to the forward diffusion model in the image reconstruction proc-
ess. This calibration also needs to account for the two different
detectors used. Prior to each experiment, a phantom with optical
properties similar to the breast (or to a heterogeneous phantom)
is imaged with both types of detectors using all available wave-
lengths. The data set consisting of the logarithm of the intensity
and phase shift from the homogenous phantom experiments are
subtracted from a calculated diffusion model of the same phan-
tom region, and this is then added onto future measurements of
heterogeneous phantoms or tissues that were imaged. This pro-
vides a fiber-by-fiber small correction, assuming additive errors
can be fixed this way.
2.6 Patient Interface
Figure 3 shows the schematic of two different breast interface
geometries. Instead of the circular patient interface [Fig. 3(a)]
that has been used with our previous generation imaging
system,13 a pentagonal patient interface [Fig. 3(b)] was designed
to accommodate various breast sizes to be imaged inside the
magnetic resonance (MR) room.20 One end of each of the 16
long fiber bundles is coupled into a breast MR coil and contacts
the breast with limited pressure for simultaneous MR and optical
imaging of patients/phantoms. The other end of each of these 16
fiber bundles is passed through a conduit in the wall and con-
nects the source and detectors in the imaging assembly located
outside the MR room. More details about this new interface are
discussed elsewhere.20
2.7 Phantom Experiments
In order to study the system in detail, tissue phantom experi-
ments were performed on a gelatin phantom mimicking breast
tissue, with a 2 cm cylindrical inclusion within, which could
have varying optical properties. The bulk optical properties of
the phantom were similar to those of breast tissue. It was con-
structed using water, type 1 agarose, 1% intralipid, and whole
porcine blood at a background concentration of 15 μM. The
Journal of Biomedical Optics 011010-4 January 2014 • Vol. 19(1)
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hematocrit level of the blood was measured by a Hemocue
device to be 8 g∕dL of the blood. The inclusion was filled
with varying concentrations of blood from 0 up to 45 μM in
5 μM increments, in order to vary the absorption systematically.
After each concentration, the phantom was imaged with all nine
wavelengths.
Images were reconstructed using Nirfast software21 to deter-
mine the accuracy in recovery of the blood concentration of each
run as compared to the expected concentrations. Briefly, the dif-
ference between measured data and a diffusion-based model of
light propagation through the medium22–24 is minimized to yield
estimates of the optical properties of the tissue of interest. The
three-dimensional reconstruction algorithm was designed to
employ a priori information gained from MRI to guide the opti-
cal solution as outlined in previous work by Carpenter et al.25,26
This technique makes the assumption that each of the segmented
regions defined from the MR, adipose, and fibroglandular have
similar optical properties throughout. We simplify the image
reconstruction problem computationally by completely elimi-
nating variation within regions and, thus, are able to quantify
optical properties between regions but not within them.26 We
also use spectral priors in the reconstruction, solving directly
for tissue chromophores rather than absorption (μa) and scatter-
ing (μ 0s) coefficients at each wavelength as outlined in previous
work.23–25,27 These methods were applied to both phantom and
human subject image reconstruction.
2.8 Healthy Subject Imaging
All human subjects imaging has been carried out under an insti-
tutional review board approved protocol, #11487, and subjects
have given informed consent prior to entering the study. Imaging
protocol for the human subject examination was approved
by the Committee for the Protection of Human Subjects at
Dartmouth-Hitchcock Medical Center. The subjects were posi-
tioned into the clinical MR breast coil and optical fibers were
moved into contact with the breast tissue. If a fiber was unable
to contact the breast, data from that fiber were omitted.
Coregistration between optical and MR images was done using
MR fiducial markers in the plane of the fibers and bilateral
MR images in the axial geometry. Optical and MR data
were collected concurrently, with data collections taking 12




In order to determine the sensitivity and linearity of each detec-
tor, a fixed optical signal along with neutral density (ND) filters
were used to look at the detector’s response as a function of
incident light power. The light power was increased incremen-
tally by removing the ND filters from the path of the laser beam
while the AC amplitude and phase response of the PMTs and the
AC amplitude of the PDs were recorded. The AC signal error
and phase error as a function of incident power for one of the
PMTs for this system is shown in Fig. 4. The results are com-
pared to the previous generation system built in our lab13 in
order to demonstrate the improvement of the new system over
the older one. The full dynamic range of the PMTs was about
1 × 105 with the lowest signal detected at around 0.01 nW using
the highest gain setting. Adding the RF amplifiers to the system
has helped in increasing the SNR of the FD measurements.
Figure 5 shows the response of one of the PDs as a function
of light power for the two gain settings of the PD. The low range
exhibits linearity over the range of 0.1 nW up to 2 uW, while the
high gain setting exhibits linearity over the range of 1 pW up to
20 nW. Thus, the full dynamic range of the PDs is 2 × 106.
3.2 Gain Settings
PMT detectors nearest to the light source receive orders of mag-
nitude more light than detectors that are farther away. In order
to account for this variability, the gain of the PMT detectors
must be adjusted accordingly. The gain of the PMT detectors
is adjusted by adjusting an analog control voltage input, which
is controlled via a static analog voltage output NI-6073 card
from National Instruments.
Prior to acquisition, the PMTwould be set to the lowest gain
possible (0.3 V). The gain of each PMT is then increased in
0.1 V increments while monitoring the PMT output AC signal.
Once the AC signal reaches a user-defined threshold, the gain of
that particular PMT is set. The process continues until all PMT
gain values have been set or until the gain reaches a maximum
user-defined value. The system waits for 100 ms during the
process of finding the proper gain before acquiring and analyz-
ing the AC signal. However, once the gains have been set for
all PMTs, the system waits for an additional 1000 ms to ensure
better stability of all PMTs.
Fig. 3 Schematic of two different breast interface geometries: circular (a) and the new pentagonal interface (b).
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As mentioned previously, the sensitivity of the PD modules
is switchable between a low and a high range using a switch on
the back of the PD module. The two PDs nearest to the laser
source receive much more light than the remaining modules
and therefore had to be set to low-sensitivity range in order
to avoid detector saturation. A high-sensitivity setting was used
for the remaining modules since the amount of light received
by these detectors is below the saturation point of the high-
sensitivity range.
In order to improve the performance of the system even
further, a programmable amplifier on board the DAQ card was
used. During acquisition, data from each channel (FD and CW)
is sampled for 100 ms in order to find the maximum and mini-
mum of each channel. Once this range is found, the appropriate
gain is selected for each individual channel and the signals are
acquired again. This ensures that the maximum ADC resolution
is used while acquiring all signals.
3.3 Cross-Talk
There are two types of cross-talk that may affect the results of
the system. The first type is an inherent property of the PMT,
where increasing the light intensity of a signal while maintaining
the phase influences the phase readout. This is due to space
charge effects of the PMT. In order to minimize this cross-
talk, we start the PMT at the lowest possible gain and increase
the gain in discrete steps until the signal is above the noise floor
of the system, but well below the saturation level of the PMT.
Once the signal level reaches a user-defined minimum value,
which is approximately the middle of the dynamic range of
the PMT, the gain is set. This method ensures that the PMT
anode current does not reach large values that may disturb the
electric field inside the PMT and cause the phase to change.
The other type of cross-talk that may affect the measurement
is interchannel cross-talk from the DAQ card. This type of cross-
talk may be improved if differential measurements are used.
However, due to system limitations, our system had to use the
single-ended termination where all the signals share the same
ground point. This causes cross-talk between channels if one
channel detects a larger signal compared to its neighboring
channels. However, the same method that improves the space
charge cross-talk affect also improves the interchannel cross-
talk. By increasing the gain of each PMT until the signal is
in the middle of the dynamic range for all PMTs, the voltage
read by the DAQ device is roughly the same for all channels.
3.4 Stability and Repeatability
The repeatability of the system was determined by repeating a
phantom measurement continuously while keeping all the
parameters in the experiment the same. The phantom used is
a silicon phantom with diameter of 86 mm. The laser light
was directed to the center of the phantom. The phantom experi-
ment was run five times and the standard deviation of the phase
as well as the standard deviation of the natural log of the ampli-
tude (In AC) was calculated. It was found that the average
repeatability of the phase and In AC is 0.2 deg and 0.5%, respec-
tively, as compared to 0.4 deg and 0.5% for our previous system.
In order to measure the stability of the system, the same
repeatability experiments were performed over an entire week,
ensuring that the system is turned on and off prior to the experi-
ments. It was found that the average stability of the phase and
In AC is 0.44 deg and 1.2%, respectively.
3.5 Data Acquisition Duration and Timing
Experiment duration is very important when patients are
involved in imaging. Several improvements were implemented
in order to shorten the duration of the full nine-wavelength
acquisition, including optimizing the way PMT gains are calcu-
lated for different source position as well as refining software
procedures.
During FD acquisition, for gain routine A, the first laser is
activated and the rotary stage moves until the source and detec-
tors are aligned with the first source position [e.g., Fig. 2(a)].
The gain finding routine sets the PMTs to the proper gain and
then data from all PMTs are acquired. Next, the rotary stage
moves to the next source position, sets the proper gain, and
Fig. 5 Photodiode (PD) response as a function of incident light power
for the two available gain settings of the PD.
Fig. 4 Standard deviation of the natural log of the amplitude (ln AC)
(a) as well as the standard deviation of the phase (b) of the photomulti-
plier tube as a function of incident light power. The blue marks re-
present the results for the new system, while the red marks represent
the results for the system built by McBride et al.
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acquires the data. This continues until every source position has
been acquired. Once the results from the first wavelength are
obtained, the system repeats the same process above for the
remaining wavelengths.
Another variation to the routine above is used to reduce the
acquisition time. The second routine (routine B) reduces the
time required for calculating the PMT gain by adjusting how
the gains are calculated. It is identical to routine A above during
the acquisition of the first wavelength. However, for the remain-
ing wavelengths that are used in the acquisition, the gain values
that were found for the first wavelength are used as the initial
starting values. In both gain finding routines, once the FD
acquisition is finished, the system performs a similar process
for the CW wavelength measurements. The only difference is
that no gain finding routine is needed while acquiring data with
the PDmodules since PDmodule gains cannot be adjusted using
software.
Running an acquisition with all nine wavelengths takes any-
where from 9 to 20 min, depending on what geometry and which
gain finding routine are used during the acquisition. The total
data acquisition time for each wavelength is shown in
Table 1. In addition to the total data acquisition time at each
wavelength, Table 1 shows the average time it takes for the sys-
tem to determine the gain for the PMTs (column: Gain); for
movement of the rotary switch array (column: Motor); and for
miscellaneous steps, which include toggling the lasers, setting
up the function generators, etc. (column: Misc). As can be
seen from Table 1, for FD measurements, the difference in the
total acquisition times is due to the geometry chosen and the
gain routine used. The circular geometry setup [Fig. 3(a)] takes
the least amount of time because this geometry requires only one
gain set of all PMTs at a single source position. For the non-
circular geometry, gain routine B approach has cut down the
time of a full nine-wavelength scan from 19 to about 12 min.
3.6 Tissue Simulating Phantom Experiments
A blood gelatin phantom was prepared as described in Sec. 2.7.
The blood concentration of the phantom background was kept
constant at 15 μM. The 2 cm inclusion was filled with different
porcine blood concentrations starting from 0 up to 45 μM in
5 μM increments (15 μM concentration was not used). With
each concentration, full FD/CW measurements were acquired
and the blood concentration was recovered using Nirfast soft-
ware.21 Figure 6 shows reconstruction results as a function of
the actual blood concentration used. Hemoglobin recovery in
the background was 25 μM compared to the actual 15 μM
concentration. The background values were very stable across
concentrations, with the norm of the residuals being 0.0054.
Recovered HbT values from the inclusion showed a linear
increase (norm of the residuals ¼ 0.0066) with an average
recovery of 71% of the true blood concentration.
3.7 Human Subject Imaging
The combined FD/CW system and pentagonal interface has
been used to successfully image nine healthy volunteers to date.
A representative case is shown in Fig. 7. The volunteer was posi-
tioned such that her breasts were centered in the MR coil to min-
imize image artifact and then lightly compressed by the fiber
optic cables to ensure good coupling. Optical data were col-
lected in ∼9 min for FD and 3 min for CW, totaling 12 min.
MRI acquisition took ∼30 min, and a second optical scan
was performed during the remaining time. Data from one fiber
were removed due to poor coupling with the breast tissue.
A three-dimensional (3-D) finite element mesh of ∼40 k
nodes was created specific to the patient based on the MR
scan and segmented into adipose and fibroglandular regions.










6 30 20 56 (∼1 min)
FD–pentagonal
geometry Routine A




40 30 20 90 (1.5 min)
CW N/A 30 26 56 (∼1 min)
Fig. 6 Reconstruction values on a gelatin phantom with 2 cm inclusion. The inclusion was filled with varying concentrations of blood. MRI images of
the phantom are shown with the 2 cm inclusion overlaid (a) and (b). A photo of the actual phantom is shown in (c). Reconstruction as a function of true
total hemoglobin values are shown for total hemoglobin, oxygen saturation, water, lipids, scatter power, and scatter amplitude in (d). Blue circles are for
the background, while red circles are for the inclusion.
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Optical data were coregistered to the MRI using fiducial markers
in line with the optical fibers and the data were calibrated abso-
lutely versus the model. A hard priors approach was then used to
reconstruct for oxygenated hemoglobin, deoxygenated hemo-
globin, water and lipid fraction, scatter amplitude, and scatter
power.21 This volunteer showed total hemoglobin concentration
of 18 μM in the adipose region and 22 μM in the glandular
region with high oxygen saturation (74 to 86%) as well.
Water content was higher in the glandular region, while lipid
content was higher in the adipose region. MRI image quality
was not affected by the optical image acquisition aside from
a slight distortion of one breast from the optical fibers. The vol-
unteer reported no discomfort due to the procedure.
4 Discussion
Imaging water and lipid concentrations poses a problem since
the ideal FD or time-resolved systems are PMT based, and so
limit their response to wavelengths that are below the main spec-
tral features of water and lipids. The ability to accurately image
water and lipid concentrations enables better characterization of
malignant and benign tissue, as well as provides better charac-
terization of cysts and is also critical to recovering accurate
hemoglobin and oxygen saturation values. The new hybrid sys-
tem presented here has extended the wavelength range in order
to include these spectral features and thus improves the data
available for separation of chromophore contributions. How-
ever, since pure CW measurements do not accurately decouple
chromophore concentrations and scattering, our system com-
bines FD and CWmeasurements. Admittedly, this technological
solution is a complicated coupling of two detection technolo-
gies; however, it is presented here in a design that allows not
only simultaneous sampling but also fast source switching. The
design is also extendable to more channels and faster speeds,
but is slightly configuration dependent in terms of timing.
A key advantage of the system is the integration of all com-
ponents into a portable standalone prototype, allowing wider
optical bandwidth of detection. The previous system used 16
spectrometers, which used CCDs to measure the light signal.
The system was a prototype extendable to different types of
spectroscopy, including fluorescence and Raman, but not ideal
for extending into highly parallel acquisition in a cost-effective
manner. The current hybrid system contains all imaging compo-
nents inside a single rack and is a logical prototype of how to
combine FD and CW detection in a package that is compact,
cost effective, and extendable.
The addition of þ20 dB amplifier after each PMT has
increased the SNR of the FD measurements. However, while
changing the gain of the PMTs provides a high working
range of linearity, the FD system was not able to detect light
signal levels as low as those detectable in the CW system. This
is likely due to the relatively low SNR of the phase measurement
by PMT. The PD modules used with the CW measurements
proved to be excellent detectors with a very high dynamic
range of 2 × 106 and detection limit at 1 pW. And unlike the
PMTs, the PD modules did not require any additional electron-
ics or RF components in order to accurately measure the light
signal; so they are be easier to integrate into a massively parallel
system. While the PD displayed better linearity and no space-
charge effect cross-talk, FD measurements of phase and ampli-
tude cannot be acquired due to the lower temporal bandwidth
of the PDs.
Another advantage of the hybrid system is that it has a band-
width between 50 and 800 MHz, allowing multiple modulation
frequencies to be used. Since an MRI scan takes a little over
30 min while an optical exam takes 12 min, it is possible to run
multiple optical scans with different modulation frequencies
during a single MRI scan, or the higher frequencies could be
used when the tissue volume is smaller. A disadvantage of our
Fig. 7 Representative healthy volunteer imaging by combined optical system and MRI. Different axial MRI slices are shown with overlays of total
hemoglobin (a), oxygen saturation (b), water (c) and lipid (d) fraction, scatter amplitude (e), and power (f). In each case, the region with the lowest value
is removed and the region with the highest value is made slightly opaque to visualize overlaidMRI. A bilateral axial image (g) shows little degradation of
MRI image quality.
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current breast interface is that a 3-D scan is not possible without
having to reposition the patient; however, the current hybrid
array can be used with a larger number of channels, in a serial
manner, if a better breast interface is developed.
The hybrid system was validated using gelatin phantom
experiments that were able to track the linear increase of blood
inside a 2-cm inclusion in a pentagonal phantom that is specific
to our clinical NIR-MRI breast coil. We found that contrast
recovery was slightly lower than expected, but this is a known
problem in DOT, and likely due to cross-talk between absorp-
tion and scatter.28,29 We found that the system displayed linear
contrast recovery over a wide range of hemoglobin concentra-
tions with stability in the background. Our system was most
accurate though with the lowest concentrations, which have
contrasts similar to what we expect to see in malignant breast
lesions.28 Additionally, several healthy volunteers have been
imaged using this system and images have been reconstructed
with results consistent with past work and literature values.7,30,31
The presented case shows elevated hemoglobin, oxygen satura-
tion, water, and scattering parameters in the glandular tissue
likely due to the higher cellular metabolism in the more complex
tissue. Lipid content was higher in adipose region, consistent
with our expectations.27 Our results show linear recovery and
good stability in phantom studies and physiologically reason-
able chromophore quantification in healthy human subjects.
These results are important milestones in the system develop-
ment and we are confident that we will have success imaging
cancer patients. Future studies in human subjects will focus
on cancer patients and accurate recovery of parameters from
differing breast sizes.
5 Conclusions
A new hybrid frequency and CW domains system was devel-
oped, which improves the data quality and accuracy in the
recovery of the breast chromophores. The system combines
PMT and PD detectors in a switch array in order to extend the
spectral range of the wavelengths used up to 948 nm. PMT
detectors are used to image tissue using wavelengths between
600 and 850 nm, after which the detector response falls off
dramatically. PD detectors are then used to image tissue using
wavelengths between 900 and 948 nm. All optical components
and imaging hardware are housed inside a portable standalone
rack. The new design is compact, cost effective, and enables
efficient parallel acquisition. After careful calibration, the sys-
tem was tested and validated using phantom experiments as
well as imaging of healthy volunteers, and the acquisition time
for imaging using all nine wavelengths was reduced to about
12 min.
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